Germany opposes U.S. plan to waive patents on COVID-19 vaccines Reuters 2 days ago
BERLIN, May 6 (Reuters) - A U.S. proposal to waive patent protection for COVID-19 vaccines would have significant implications for production, a German government spokeswoman said on Thursday, adding the main factors are capacity and quality standards rather than patents. The protection of intellectual property is a source of innovation and must remain so in the future, the spokeswoman said in a statement. (Reporting by Andreas Rinke Writing by Madeline Chambers Editing by Douglas Busvine)
UPDATE 1-Germany rejects U.S. proposal to waive patents on COVID-19 vaccines Reuters 2 days ago
(Adds detail, quotes)
BERLIN, May 6 (Reuters) - Germany on Thursday rejected a U.S. proposal to waive patent protection for COVID-19 vaccines, saying the greatest constraints on production were not intellectual property but increasing capacity and ensuring quality.
President Joe Biden on Wednesday voiced support for a waiver in a sharp reversal of the U.S. position, and his top trade negotiator, Katherine Tai, swiftly backed negotiations at the World Trade Organization.
The German government stood behind the goal of a worldwide supply of COVID-19 vaccines, a government spokeswoman said, adding however that the main factors in vaccine production are capacity and quality standards, and not patents.
Germany rejects U S proposal to waive patents on COVID-19 vaccines reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
German CDU leaders meet to discuss choice of candidate for chancellor msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.